MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0013226
Zatix Pharmaceuticals Private Limited
Zatix Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹57.7 Lakh
▲ 46% YoY
Net profit · FY 2024
₹26,180
Net margin 0.5%
EBITDA · FY 2024
₹1.43 Lakh
EBITDA margin 2.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Zatix Pharmaceuticals Private Limited
Data last updated:
Zatix Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2020PTC369040. Its GSTIN is 09AABCZ5810D1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neeraj Dixit (Whole-Time Director) and Parul Dixit (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 14/15 Kh No. 525 First Floor Block – P New Roshanpura Near Shiv Mandir, New Delhi, Delhi, India – 110043.
As per the financials filed for FY 2024, the company reported a revenue of ₹57.7 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹26,180 (net margin 0.5%) and EBITDA of ₹1.43 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years.
Zatix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0013226).
Company details
CIN U51397DL2020PTC369040
Registration Number 369040
Incorporation Date 01 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0013226
Recognitions & Rankings of Zatix Pharmaceuticals
Contact details
Zatix Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 14/15 Kh No. 525 First Floor Block – P New Roshanpura Near Shiv Mandir, New Delhi, Delhi, India – 110043
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zatix Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Zatix Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zatix Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zatix Pharmaceuticals Private Limited, buy the company report.
Financials of Zatix Pharmaceuticals Private Limited
FY 2025 filings availableZatix Pharmaceuticals Private Limited reported revenue of ₹57.7 Lakh (up 46% YoY) for FY 2024.
Revenue · FY 2024
₹57.7 Lakh ▲ 46%
Net profit · FY 2024
₹26,180 margin 0.5%
EBITDA · FY 2024
₹1.43 Lakh margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 96%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 89%
Revenue has grown at a compounded annual rate (CAGR) of 96% over three years, including 46% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.43 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹26,180 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.5% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Zatix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zatix Pharmaceuticals Private Limited
Zatix Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Dixit | Whole-Time Director | 01 Sep 2020 | 6 Years 2 Months | Current |
| Parul Dixit | Whole-Time Director | 01 Sep 2020 | 6 Years 2 Months | Current |
Peer comparison
Zatix Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esaren Pharmaceuticals Private Limited | ₹57.81 Lakh (FY 2024) | 6.0% | Kanpur, Uttar Pradesh, India | |||
| Kube Pharmaceuticals Private Limited | ₹57.79 Lakh (FY 2025) | 56.0% | Nagpur, Maharashtra, India | |||
| Radius Drug Private Limited | ₹57.77 Lakh (FY 2025) | 91.0% | Csa, Uttar Pradesh, India | |||
| Zatix Pharmaceuticals Private Limitedthis company | ₹57.7 Lakh (FY 2024) | ₹26,180 | 0.5% | 46.0% | New Delhi, Delhi, India | |
| Beyondinfinite.Com Semiconductor Private Limited | ₹57.59 Lakh (FY 2024) | 61.0% | New Delhi, Delhi, India | |||
| Ariskon Pharma Private Limited | ₹57.57 Lakh (FY 2024) | 48.0% | New Delhi, Delhi, India | |||
| Ramsar Pharmaceuticals Private Limited | ₹57.52 Lakh (FY 2025) | 2273.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Zatix Pharmaceuticals Private Limited, buy the company report.
Auditor
Zatix Pharmaceuticals Private Limited is audited by ANUBHAV SRIVASTAVA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUBHAV SRIVASTAVA & CO. | FY 2023 | 0017438C |
Shareholding
The shareholding of Zatix Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zatix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zatix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zatix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zatix Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Zatix Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCZ5810D1ZG | Uttar Pradesh | Active | 14 Oct 2020 |
To see the full GST registrations and return filing status of Zatix Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zatix Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Neeraj Dixit was appointed as Whole-Time Director on 01 Sep 2020.
AGM
Zatix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zatix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Neeraj Dixit was appointed as Whole-Time Director.
Appointed
Parul Dixit was appointed as Whole-Time Director.
Incorporation
01 Sep 2020
Zatix Pharmaceuticals Private Limited was registered on 01 Sep 2020 with Roc Delhi I & aged 6 years 2 months as per MCA records.
Frequently asked questions
Zatix Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 September 2020 (6+ years old) and is registered under CIN U51397DL2020PTC369040.
Zatix Pharmaceuticals has 2 current directors:
- Neeraj Dixit - Whole-Time Director
- Parul Dixit - Whole-Time Director
The latest financial statements of Zatix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Zatix Pharmaceuticals is 09AABCZ5810D1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Zatix Pharmaceuticals is U51397DL2020PTC369040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zatix Pharmaceuticals was incorporated on 01 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Zatix Pharmaceuticals by revenue are Esaren Pharmaceuticals Private Limited, Kube Pharmaceuticals Private Limited, Radius Drug Private Limited, Beyondinfinite.Com Semiconductor Private Limited, Ariskon Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Neeraj Dixit was appointed as Whole-Time Director on 01 Sep 2020. Parul Dixit was appointed as Whole-Time Director on 01 Sep 2020.
Yes, Zatix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0013226).
The registered office of Zatix Pharmaceuticals is at Plot No 1415 Kh No. 525 First Floor Block – P New Roshanpura Near Shiv Mandir, New Delhi, Delhi, India – 110043.
Zatix Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages